Friday, November 10, 2017 4:54:48 PM
I noted Sidney's letter to one of the shareholders and he strikes me as the type of owner and CEO that is not overly conerned with the OTC and their concerns, but first and foremost with patient care and completing the necessary steps to release and sell his product. The video opens with "patent pending" so I wonder where they are with that important benchmark.
Everything I have read, from product offering to FDA acceptance to market release status to share structure to SEC filing delinquency and commitment to meet complliance, and more importantly the man's own words - say to stick with these guys. Good things are forthcoming.
“Wo ein Wille ist, da ist auch ein Weg”
- Albert Einstein, Tokyo, 1922
Recent ALRTF News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/29/2023 12:53:49 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/28/2023 08:49:25 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM